Ravi Sarode

12.4k total citations · 6 hit papers
221 papers, 8.3k citations indexed

About

Ravi Sarode is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Ravi Sarode has authored 221 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Hematology, 65 papers in Cardiology and Cardiovascular Medicine and 59 papers in Internal Medicine. Recurrent topics in Ravi Sarode's work include Venous Thromboembolism Diagnosis and Management (59 papers), Atrial Fibrillation Management and Outcomes (45 papers) and Complement system in diseases (39 papers). Ravi Sarode is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (59 papers), Atrial Fibrillation Management and Outcomes (45 papers) and Complement system in diseases (39 papers). Ravi Sarode collaborates with scholars based in United States, India and Canada. Ravi Sarode's co-authors include Majed A. Refaai, Han‐Mou Tsai, Truman J. Milling, Joshua N. Goldstein, Billie L. Durn, Zbigniew M. Szczepiorkowski, Marisa B. Marques, Jeffrey L. Winters, Astrid Schneider and Antoinette Mangione and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Ravi Sarode

207 papers receiving 8.1k citations

Hit Papers

Mutations in a member of the ADAMTS gene family cause thr... 2001 2026 2009 2017 2001 2013 2019 2015 2017 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Sarode United States 43 2.9k 2.7k 2.2k 1.6k 1.3k 221 8.3k
Ian Mackie United Kingdom 52 4.4k 1.5× 1.9k 0.7× 1.8k 0.8× 1.8k 1.1× 1.1k 0.9× 227 9.7k
Samuel J. Machin United Kingdom 53 4.4k 1.5× 3.1k 1.1× 1.4k 0.6× 1.2k 0.7× 1.7k 1.3× 205 9.5k
Guido Reber Switzerland 38 4.1k 1.4× 1.7k 0.6× 1.5k 0.7× 2.0k 1.2× 1.1k 0.8× 114 9.9k
Armando D’Angelo Italy 46 3.0k 1.0× 950 0.4× 2.4k 1.1× 2.6k 1.6× 324 0.3× 192 9.1k
Frank W.G. Leebeek Netherlands 57 6.1k 2.1× 963 0.4× 2.1k 0.9× 1.7k 1.0× 288 0.2× 392 12.3k
Paul A. Kyrle Austria 52 6.2k 2.2× 1.6k 0.6× 3.9k 1.7× 5.8k 3.5× 773 0.6× 209 11.8k
Adam Cuker United States 46 4.2k 1.5× 658 0.2× 2.5k 1.1× 3.0k 1.8× 359 0.3× 224 9.0k
Thomas S. Kickler United States 38 2.6k 0.9× 1.0k 0.4× 1.1k 0.5× 589 0.4× 512 0.4× 174 5.6k
Joan Carles Reverter Spain 42 2.1k 0.7× 835 0.3× 1.0k 0.5× 686 0.4× 389 0.3× 222 6.3k
Wendy Lim Canada 41 3.8k 1.3× 508 0.2× 3.5k 1.6× 4.3k 2.6× 537 0.4× 112 10.0k

Countries citing papers authored by Ravi Sarode

Since Specialization
Citations

This map shows the geographic impact of Ravi Sarode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Sarode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Sarode more than expected).

Fields of papers citing papers by Ravi Sarode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Sarode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Sarode. The network helps show where Ravi Sarode may publish in the future.

Co-authorship network of co-authors of Ravi Sarode

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Sarode. A scholar is included among the top collaborators of Ravi Sarode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Sarode. Ravi Sarode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nero, Alecia, et al.. (2025). Hyperhemolysis in a sickle cell disease patient in pregnancy. Annals of Hematology. 104(8). 4245–4249.
4.
Friedman, Kenneth D., Dennis J. Dietzen, Charles Eby, et al.. (2024). Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays. Research and Practice in Thrombosis and Haemostasis. 8(4). 102422–102422. 2 indexed citations
5.
Adkins, Brian D., et al.. (2024). How do we manage hyperhemolysis syndrome. Transfusion. 64(10). 1822–1829.
6.
Sarode, Ravi, Ian J. Welsby, & Maureane Hoffman. (2023). Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants. Annals of Emergency Medicine. 82(3). 341–361. 4 indexed citations
7.
Clark, Andrew E., Zhaohui Wang, Huiyu Yao, et al.. (2022). Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern. Clinical Chemistry. 68(8). 1042–1052. 12 indexed citations
8.
Narasimhan, Madhusudhanan, Lenin Mahimainathan, Ellen Araj, et al.. (2021). Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups. Journal of Clinical Microbiology. 59(7). e0038821–e0038821. 80 indexed citations
9.
Cuker, Adam, Spero R. Cataland, Paul Coppo, et al.. (2021). Redefining outcomes in immune TTP: an international working group consensus report. Blood. 137(14). 1855–1861. 121 indexed citations
10.
Phipps, William S., Jeffrey A. SoRelle, Quan‐Zhen Li, et al.. (2020). SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity. American Journal of Clinical Pathology. 154(4). 459–465. 46 indexed citations
11.
Zhang, Song, et al.. (2020). Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trial. Blood Advances. 4(15). 3767–3775. 8 indexed citations
12.
Hofmann, Sandra L., et al.. (2020). Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission. Transfusion and Apheresis Science. 59(6). 102885–102885. 6 indexed citations
13.
Tomaselli, Gordon F., Kenneth W. Mahaffey, Adam Cuker, et al.. (2020). 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants. Journal of the American College of Cardiology. 76(5). 594–622. 201 indexed citations breakdown →
14.
Jain, Nishank, Fei Wan, Monica T. Kothari, et al.. (2019). Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial. BMC Nephrology. 20(1). 395–395. 12 indexed citations
15.
Tawfik, Bernard, et al.. (2016). Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency. Transfusion and Apheresis Science. 55(3). 364–367. 2 indexed citations
16.
Yates, Sean G. & Ravi Sarode. (2013). Novel thrombin and factor Xa inhibitors. Current Opinion in Hematology. 20(6). 552–557. 13 indexed citations
17.
Sarode, Ravi, et al.. (2005). Poor correlation of supratherapeutic international normalised ratio and vitamin K‐dependent procoagulant factor levels during warfarin therapy. British Journal of Haematology. 132(5). 604–607. 26 indexed citations
18.
Downes, Katharine A., Roslyn Yomtovían, Han‐Mou Tsai, et al.. (2004). Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident. Journal of Clinical Apheresis. 19(2). 86–89. 41 indexed citations
19.
Levy, Gallia G., William C. Nichols, Eric C.‐Y. Lian, et al.. (2001). Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 413(6855). 488–494. 1254 indexed citations breakdown →
20.
Marwaha, Neelam, Ravi Sarode, R. K. Marwaha, et al.. (1990). Bilirubin crystals in peripheral blood smears from neonates with unconjugated hyperbilirubinaemia.. PubMed. 47(4). 278–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026